Exhibition:
71st AACC Annual Scientific Meeting & Clinical Lab Expo
Anaheim, California
Exhibition dates:
August 6-8, 2019
Venue:
Anaheim Convention Center
800 West Katella Avenue
Anaheim, CA 92802
(714) 765-8950
Booth Number: 2952
Stanbio
an EKF Diagnostics Company
Website:
71st AACC Annual Scientific Meeting
& Clinical Lab Expo
At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, you’ll have the opportunity to:
- Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
- Learn about cutting edge technology. The AACC Clinical Lab Expo has more than 200 new product introductions each year.
- Hear vital research and learn about important changes in the field. With nearly 300 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, you can design an educational experience that meets your need to stay ahead of changes in the field.
Products Displayed:
Point of Care
DiaSpect Tm Hgb
HemoPoint H2 Hgb
Quo-Test HbA1c
Creamatocrit Plus
Central Laboratory
ß-Hydroxybutyrate Test
Altair 240 Chemistry Analyzer
STAT-Site M ß-Hydroxybutyrate
Lucica® Glycated Albumin-L
Life Sciences
Mr. Takuji Kohzuma
Mr Takuji Kohzuma Ph.D. Senior Manager, IVD Kit Product Group from Asahi Kasei Pharma is the inventor of the enzymatic method for Glycated Albumin and will be on our booth at AACC.
Mr Kohzuma has worked for Asahi Kasei Corp. since 1989. His career is full of achievements, several scientific reports and patents:
Company
1989 Asahi Kasei Corp.
2005 Asahi Kasei Pharma Corp.
Academic background
1987 Bachelor of Science: Kyushu University (Japan)
1989 Master of Science: Kyushu University (Japan)
2006 Doctor of Pharmacology: Kyushu University (Japan)
Career
2002 Published first report of the “Enzymatic method for Glycated Albumin” (Clin Chim Acta)
2002 A member of a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry
2005 “Prize of technology” from Japan Society of Clinical Chemistry
2008 Reported the “JSCC Recommended Method for Glycated Albumin Measurement in Serum” as one of authors of Committee” on Journal of “Rinsho Kagaku”
2014 Adviser for a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry
2015 Reported the “Reference measurement Procedure and reference materials for GA determination (Annals Clin. Biochem.)
Others（July 2019）
Scientific reports: 29, including “Diabetologia”, “Atherosclerosis”, “Clinica Chimica Acta”, etc.
Patents: 55 including 6 of international patents, ”Composition for assaying glycated protein”
EKF’ Staff Attending:
Mike Salter – President, EKF Americas
Jami Meeks – VP Strategic Business Development
Trevor McCarthy – Global Business Development Manager, Central Laboratory
Shane O’Neill – Global Director Scientific Affairs
Bart Battles – Sales Director/U.S. & Canada/Acute Care, Alternate Care, & Public Health
Brian Griffin – Sales Director/U.S. & Canada/Blood Banks & Plasma
Sergio Stilman – Sales Director/Latin America
Allan Leest – Regional Sales Manager/Latin America
Gino Rampolla – Regional Sales Manager/U.S. Southeast
Ed Balmelli – Regional Sales Manager/U.S. West